Pds biotech reports second quarter 2023 financial results and provides business update

Princeton, n.j., aug. 14, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (pds biotech or the company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the company's proprietary t cell activating platforms, will discuss its financial results for the quarter ended june 30, 2023 and provide a business update on its conference call today.
PDSB Ratings Summary
PDSB Quant Ranking